Dovitinib

405169-16-6

C-Fms|||VEGFR|||FGFR|||FLT|||c-Kit|||PDGFR

Tyrosine Kinase/Adaptors|||Angiogenesis

0.9992

Dovitinib is an orally active, multi-targeted tyrosine kinase (RTK) inhibitor with anti-tumor effects.

CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O

C21H21FN6O

392.43

Cool pack

-20°C